III Thriller Extrait de Parfum by Maison Asrar x Cal Cologne
III Thriller opens with an electrifying burst of lemon, cardamom, bergamot, saffron, elemi, and pepper — a fresh and spicy combination that strikes fast and commands attention.
At the heart, clary sage, labdanum, leather, tonka beans, and incense bring darkness and intensity. The leather adds a smoky edge while the incense creates an almost ritualistic depth. Tonka beans provide a subtle sweetness that keeps the composition from becoming too austere.
The dry-down reveals a rich, enveloping base of sandalwood, benzoin, amber, musk, vanilla, and cashmeran — smooth but relentless, like the moment you realize there's no turning back. The vanilla and cashmeran add a velvety warmth that lingers on the skin for hours.
III Thriller is a 2026 collaboration between Maison Asrar and Cal Cologne, delivering an Aromatic Woody Extrait de Parfum that's bold, seductive, and built for impact. Perfect for evening wear and cooler weather, with impressive longevity and moderate-to-strong projection.
Original: $3.95
-65%$3.95
$1.38
Description
III Thriller opens with an electrifying burst of lemon, cardamom, bergamot, saffron, elemi, and pepper — a fresh and spicy combination that strikes fast and commands attention.
At the heart, clary sage, labdanum, leather, tonka beans, and incense bring darkness and intensity. The leather adds a smoky edge while the incense creates an almost ritualistic depth. Tonka beans provide a subtle sweetness that keeps the composition from becoming too austere.
The dry-down reveals a rich, enveloping base of sandalwood, benzoin, amber, musk, vanilla, and cashmeran — smooth but relentless, like the moment you realize there's no turning back. The vanilla and cashmeran add a velvety warmth that lingers on the skin for hours.
III Thriller is a 2026 collaboration between Maison Asrar and Cal Cologne, delivering an Aromatic Woody Extrait de Parfum that's bold, seductive, and built for impact. Perfect for evening wear and cooler weather, with impressive longevity and moderate-to-strong projection.
